These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 24924904

  • 1. Expression of epithelial cell adhesion molecule associated with elevated ductular reactions in hepatocellar carcinoma.
    Xu M, Qian G, Xie F, Shi C, Yan L, Yu L, Zheng T, Wei L, Yang J.
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):699-705. PubMed ID: 24924904
    [Abstract] [Full Text] [Related]

  • 2. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW.
    Cancer Res; 2008 Mar 01; 68(5):1451-61. PubMed ID: 18316609
    [Abstract] [Full Text] [Related]

  • 3. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS, Noh SJ, Jang KY, Park HS, Chung MJ, Park CK, Moon WS.
    Int J Oncol; 2012 Dec 01; 41(6):2150-8. PubMed ID: 22993038
    [Abstract] [Full Text] [Related]

  • 4. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J.
    Hepatology; 2013 Apr 01; 57(4):1458-68. PubMed ID: 23175471
    [Abstract] [Full Text] [Related]

  • 5. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, Tani T, Zen Y, Kaneko S.
    Cancer Res; 2010 Jun 01; 70(11):4687-97. PubMed ID: 20484035
    [Abstract] [Full Text] [Related]

  • 6. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T, Budhu A, Forgues M, Wang XW.
    Cancer Res; 2007 Nov 15; 67(22):10831-9. PubMed ID: 18006828
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW, Tong JH, Chan SL, Lai PB, To KF.
    Histopathology; 2014 Jun 15; 64(7):935-50. PubMed ID: 24506513
    [Abstract] [Full Text] [Related]

  • 9. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y, Wang Y, Gong J, Rao L, Wu Z, Nie T, Shi D, Zhang L.
    Int J Oncol; 2018 Jan 15; 52(1):219-230. PubMed ID: 29138811
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B, Cavard C, Perret C.
    J Hepatol; 2010 Feb 15; 52(2):280-1. PubMed ID: 20006402
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status.
    Shan YF, Huang YL, Xie YK, Tan YH, Chen BC, Zhou MT, Shi HQ, Yu ZP, Song QT, Zhang QY.
    Med Oncol; 2011 Dec 15; 28(4):1012-6. PubMed ID: 20571936
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
    Nagahara T, Shiraha H, Sawahara H, Uchida D, Takeuchi Y, Iwamuro M, Kataoka J, Horiguchi S, Kuwaki T, Onishi H, Nakamura S, Takaki A, Nouso K, Yamamoto K.
    Oncol Rep; 2015 Sep 15; 34(3):1169-77. PubMed ID: 26165819
    [Abstract] [Full Text] [Related]

  • 17. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Zhou L, Zhu Y.
    Int J Surg; 2018 Aug 15; 56():274-280. PubMed ID: 29936198
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. EpCAM-targeted therapy for human hepatocellular carcinoma.
    Ogawa K, Tanaka S, Matsumura S, Murakata A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanabe M, Arii S.
    Ann Surg Oncol; 2014 Apr 15; 21(4):1314-22. PubMed ID: 24370904
    [Abstract] [Full Text] [Related]

  • 20. EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.
    Noh CK, Wang HJ, Kim CM, Kim J, Yoon SY, Lee GH, Cho HJ, Yang MJ, Kim SS, Hwang JC, Cho SW, Roh J, Kim YB, Kim SJ, Kim BW, Cheong JY.
    Anticancer Res; 2018 Jul 15; 38(7):4101-4109. PubMed ID: 29970536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.